https://www.businesswire.com/news/home/20230531005356/en/Alpha-Cancer-Technologies-Presents-New-Data-from-ACT-903-an-AFP-Maytansine-Conjugate-in-Online-Publication-at-the-2023-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting
Alpha Cancer Technologies Presents New Data from ACT-903, an AFP-Maytansine Conjugate, in Online...
ACT Presents New Data from ACT-903 in Online Publication at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting